Gómez‐Escribano, Ana P https://orcid.org/0000-0003-4391-5932
Mora‐Martínez, Carlos https://orcid.org/0000-0002-0542-2654
Roca, Marta https://orcid.org/0000-0003-0708-6364
Walker, Denise S https://orcid.org/0000-0003-1534-1679
Panadero, Joaquín
Sequedo, Maria D https://orcid.org/0000-0003-4885-768X
Saini, Ratni
Knölker, Hans‐Joachim https://orcid.org/0000-0002-9631-5239
Blanca, Jose
Burguera, Juan
Lahoz, Agustin
Cañizares, Joaquin
Millán, José M https://orcid.org/0000-0002-7211-9129
Burton, Nick O
Schafer, William R https://orcid.org/0000-0002-6676-8034
Vázquez‐Manrique, Rafael P https://orcid.org/0000-0002-1594-0033
Funding for this research was provided by:
Asociación Valenciana de Enfermedad de Huntington (2016/0585)
Colegio Oficial de Farmeceuticos de Sevilla‐Fundación Cajasol (2919)
Fundación Ramón Areces (CIVP19S8119)
MEC | Instituto de Salud Carlos III (CPII16/00004)
MEC | Instituto de Salud Carlos III (PI17/00011)
MEC | Instituto de Salud Carlos III (PI20/00114)
Medical Research Council, as part of United Kingdom Research and Innovation (MC‐A023‐5PB91)
Article History
Received: 8 June 2022
Revised: 2 March 2023
Accepted: 22 March 2023
First Online: 27 April 2023
Disclosure and competing interests statement
: The authors declare that they have no conflict of interest.